Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.42 (
DTA
)
1,693
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nanostructured scandium hydrous oxides were hydrothermally synthesized at 180 degrees C for 18 h, using NaOH, NH(4)OH, and KOH as the bases. They were characterized by means of X-ray diffraction (XRD), transmission electron microscopy (TEM), N2 adsorption, thermogravimetry and differential thermal analysis (TG-DTA), infrared and Raman spectroscopy, and pyridine adsorption. XRD and TEM measurements showed that the nature and concentration of the bases played key roles in determining the phasic composition, texture behavior (shape and size), and surface chemistry of the hydrothermal products. In addition, the shape evolution of the crystalline products seemed to be closely connected with their crystal structures. As the basicity value was raised from pH 10 to 5 mol L(-1) NaOH (or KOH), alpha-ScOOH nanorods, alpha-ScOOH nanosized hexagonal-like plates, and cubic Sc(OH)3 cubes/cuboids in micrometer size were produced in turn; while within pH 10-12 using
NH4OH
, gamma-ScOOH nanosized lozenge-like plates were mainly obtained. According to XRD, TEM, and TG-
DTA
results, all the as-prepared nanostructured ScOOH and micrometric Sc(OH)3 could be converted to cubic Sc2O3 with sustained crystalline shape via calcination at 500 degrees C. Pyridine adsorption revealed the existence of Lewis acid sites on the surfaces of the nanostructured alpha-ScOOH samples and some of their Sc2O3 counterparts calcined at 700 degrees C. The alpha-ScOOH nanorod sample displayed the strongest Lewis acidity among all the samples tested, due to its highest surface area as determined by N2 adsorption. Finally, an olation-oxolation process based on a dissolution/recrystallization mechanism accounts for the formation of various ScOOH polymorphs and Sc(OH)3 with different shapes.
...
PMID:Phase evolution, texture behavior, and surface chemistry of hydrothermally derived scandium (hydrous) oxide nanostructures. 1685 58
Simultaneous uptake of Ni2+, NH4+, and PO4(3-) by amorphous CaO-Al2O3-SiO2 (C-A-S) compounds was investigated using batch and column methods. Fifteen different C-A-S samples with systematically varied chemical compositions were prepared by coprecipitation from ethanol-water solutions containing Ca(NO3)2.4H2O, Al(NO3)3.9H2O, and Si(OC2H5)4, using
NH4OH
as the precipitating agent. The resulting precipitates were dried and heated at various temperatures to produce the C-A-S samples, which were then characterized by XRD, FTIR, solid state MAS NMR,
DTA
-TG, and N2 adsorption. All the C-A-S samples prepared at 600-900 degrees C were amorphous, apart from the CaO-rich samples. Simultaneous uptake of Ni2+, NH4+, and PO4(3-) was determined by a batch method using a solution with an initial concentration of 2 mM. In these experiments, the uptake abilities of the C-A-S samples for Ni2+ and PO4(3-) were high, but were relatively low for NH4+. The uptake abilities for Ni2+ and PO4(3-) increased but that for NH4+ decreased as the silica content in the C-A-S decreased, suggesting that similar uptake mechanisms (ion substitution and/or precipitation) are operating for Ni2+ and PO4(3-), but the uptake mechanism for NH4+ is different (physical adsorption). The column experiments indicate that the order of uptake ability of C-A-S for the three ions is NH4+ << PO4(3-) < Ni2+. Although the silica content of the C-A-S does not have the expected influence on the uptake of these three ions, for NH4+ it plays an important role in the formation of the amorphous phase and also in the suppression of Ca2+ and/or Al3+ release from the C-A-S during the uptake experiments. The optimum uptake properties of the C-A-S can thus be controlled by adjusting the chemical compositions and heating conditions under which the samples are prepared.
...
PMID:Simultaneous uptake of Ni2+, NH4+ and PO4(3-) by amorphous CaO-Al2O3-SiO2 compounds. 1706 11